Artificial Pancreas Implantables -- How Healthcare Professionals May Deal With DIY Bio Cases
Authors: Austin James, Xavier-Lewis Palmer, Lucas Potter et al.
Summary
arXiv:2605. 20208v1 Announce Type: new Abstract: Automated insulin delivery (AID) and artificial pancreas systems increasingly serve as safety-critical cyber-physical technologies in clinical care, integrating sensors, algorithms, software, and insulin-delivery hardware to automate a life-sustaining therapy.
Relevance
Read next because Artificial Pancreas Implantables -- How Healthcare Professionals May Deal With DIY Bio Cases overlaps with clean result "Only continuous soft prefixes hit both EM axes at once on Qwen-2.5-7B-Instruct: discrete prompt searches split between the alignment objective and the distributional objective, and both discretizations of the soft prefix collapse (MODERATE confidence)", clean result "The marker is a representational handle, not a behavioural one — sharing it between a villain persona and the assistant transfers no misalignment (HIGH confidence)", experiment "Add C2 control arm (donor sees marker_B without marker_A) to disambiguate paired-marker binding from marker_B leaking alone". Matching terms: soft, rate, control, without. Source: arxiv cs.CR (Cryptography and Security).
Abstract
arXiv:2605.20208v1 Announce Type: new Abstract: Automated insulin delivery (AID) and artificial pancreas systems increasingly serve as safety-critical cyber-physical technologies in clinical care, integrating sensors, algorithms, software, and insulin-delivery hardware to automate a life-sustaining therapy. While regulated commercial systems are supported by formal approval pathways, manufacturer governance, and post-market surveillance, clinicians are also encountering patients who rely on do-it-yourself (DIY) artificial pancreas systems that operate outside conventional regulatory and institutional control structures. This paper examines how routine clinical handling practices intersect with cyberbiosecurity risk across both regulated and DIY AID systems. When insulin delivery systems are fundamentally reconfigured into a bespoke AID system, with the patient-user becoming the primary threat vector by assuming manufacturer-level roles without mandated governance, the entire ecosystem of stakeholders is placed in legal and clinical uncertainty.